Ausgabe 2/2024
Inhalt (11 Artikel)
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
Camille Allard, Daniela Cota, Carmelo Quarta
A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
Michael A. Norred, Zachary D. Zuschlag, Mark B. Hamner
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature
Willemijn A. M. Schonck, Erik S. G. Stroes, G. Kees Hovingh, Laurens F. Reeskamp
Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota
Linhai Cao, Hongxia Ni, Xiaoxiao Gong, Ziyan Zang, Hui Chang
Methadone for Cancer Pain Management in Children: A Review of Literature
Sebastiano Mercadante
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry
Jonathan Schimmel, Lindsey Claire Epperson, Kim Aldy, Paul Wax, Jeffrey Brent, Jennie Buchanan, Michael Levine, Keith Burkhart